found that alleviation of hyperlipidemia was concomitant with downregulated expression of glycerolipid metabolism-related genes, including Lpin1, Hadha, Aldh3a2, Acox1, Elovl3, Elovol5, and Agpat3 (He et al., 2022). The gene discussed is AGPAT3; the disease is hyperlipidemia.